Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/KS/Olathe
Updated October 2026 from ClinicalTrials.gov

Paid Clinical Trials in Olathe, KS

Studies commonly pay $75 to $4,500 per completed study

1,042 clinical trials are currently recruiting participants within 30 miles of Olathe. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

1,042studies recruiting
9+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Olathe right now

Top 25 of 1,042 recruiting studies, sorted by proximity — each links to its official registry page

One-Time DNA Study for Vasculitis

Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Giant Cell Arteritis N/A Observational 1,000 participants sought
University of Kansas Medical Center — Kansas City, Kansas (19.0 mi) · Sponsor: University of Pennsylvania
See eligibility & contact on ClinicalTrials.gov (NCT01241305)

Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A

Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia Phase 1 Interventional 40 participants sought
Children's Mercy Hospital — Kansas City, Missouri (19.8 mi) · Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois
See eligibility & contact on ClinicalTrials.gov (NCT05500807)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Children's Mercy Hospitals and Clinics — Kansas City, Missouri (19.8 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy

Chronic Graft-versus-host Disease (cGVHD) Phase 2 Interventional 120 participants sought
University of Kansas Cancer Center — Kansas City, Kansas (19.0 mi) · Sponsor: H. Lee Moffitt Cancer Center and Research Institute
See eligibility & contact on ClinicalTrials.gov (NCT06660355)

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Breast Cancer Phase 3 Interventional 450 participants sought
HCA Midwest Health — Kansas City, Missouri (19.8 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT06790693)

Nutrition OUtReach In Systems of Healthcare

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, Autologous Haemopoietic Stem Cell Transplant N/A Interventional 210 participants sought
University of Kansas Cancer Center — Fairway, Kansas (13.9 mi) · Sponsor: University of Kansas Medical Center
See eligibility & contact on ClinicalTrials.gov (NCT06802406)

WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis Phase 2 Interventional 164 participants sought
WISPer site in Kansas City, KS — Kansas City, Kansas (19.0 mi) · Sponsor: Mediar Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT06967805)

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

PIK3CA Mutation, HER2- Negative Breast Cancer Phase 3 Interventional 540 participants sought
University of Kansas Cancer Center — Westwood, Kansas (15.4 mi) · Sponsor: Relay Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06982521)

A Study of Buntanetap in Participants With PD

Parkinson's Disease (PD), Deep Brain Stimulation Phase 2, Phase 3 Interventional 500 participants sought
University of Kansas Medical Center (KUMC) - School of Medicine - Parkinson's Disease and Movement D — Kansas City, Kansas (19.0 mi) · Sponsor: Annovis Bio Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07284784)

Phase 2 Study to Assess the Safety and Efficacy of ANG003

Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF) Phase 2 Interventional 113 participants sought
University of Kansas Medical Center — Kansas City, Kansas (19.0 mi) · Sponsor: Anagram Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07450547)

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
The University of Kansas Cancer Center - Olathe — Olathe, Kansas (0.1 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer, c-MET Phase 3 Interventional 768 participants sought
St. Lukes Hosp. of Kansas City /ID# 259940 — Kansas City, Missouri (19.8 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT04928846)

A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)

Limb Girdle Muscular Dystrophy, Limb-Girdle Muscular Dystrophy Type 2 Phase 1, Phase 2 Interventional 10 participants sought
University of Kansas Medical Center — Kansas City, Kansas (19.0 mi) · Sponsor: AskBio Inc
See eligibility & contact on ClinicalTrials.gov (NCT05230459)

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Solid Tumor, Adult, Metastatic Breast Cancer Phase 1 Interventional 392 participants sought
St. Lukes Hospital of Kansas City — Kansas City, Missouri (19.8 mi) · Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
See eligibility & contact on ClinicalTrials.gov (NCT06625775)

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer Phase 3 Interventional 590 participants sought
The University of Kansas Cancer Center — Westwood, Kansas (15.4 mi) · Sponsor: Revolution Medicines, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06881784)

A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)

Colo-rectal Cancer Phase 2 Interventional 79 participants sought
University of Kansas Cancer Center — Kansas City, Kansas (19.0 mi) · Sponsor: NSABP Foundation Inc
See eligibility & contact on ClinicalTrials.gov (NCT07058012)

Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)

Common Warts, Common Warts (Verruca Vulgaris) Phase 3 Interventional 300 participants sought
DelRicht Research — Overland Park, Kansas (10.5 mi) · Sponsor: Verrica Pharmaceuticals Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07637734)

PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

Parkinson Disease N/A Observational 4,500 participants sought
University of Kansas Medical Center — Kansas City, Kansas (19.0 mi) · Sponsor: Michael J. Fox Foundation for Parkinson's Research
See eligibility & contact on ClinicalTrials.gov (NCT04477785)

Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor

HPV-unrelated Head and Neck Squamous Cell Carcinoma Phase 3 Interventional 81 participants sought
Saint Luke's Hospital — Kansas City, Missouri (19.8 mi) · Sponsor: Washington University School of Medicine
See eligibility & contact on ClinicalTrials.gov (NCT04966481)

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

Large B-cell Lymphoma Phase 2 Interventional 250 participants sought
The University of Kansas Hospital — Kansas City, Kansas (19.0 mi) · Sponsor: Allogene Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT06500273)

A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) N/A Observational 30 participants sought
University of Kansas Medical Center Research Institute, Inc. — Kansas City, Kansas (19.0 mi) · Sponsor: Takeda
See eligibility & contact on ClinicalTrials.gov (NCT06538064)

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

Systemic Lupus Erythematosus Phase 3 Interventional 450 participants sought
Sl0044 50074 — Kansas City, Kansas (19.0 mi) · Sponsor: UCB Biopharma SRL
See eligibility & contact on ClinicalTrials.gov (NCT06617325)
Actively enrolling

Studies you may be able to join near Olathe

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Olathe

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Johnson County Clin Trials - JCCT

★ 4.7
16400 College Blvd, Lenexa, KS 66219
(913) 825-4400
"Always on time and professional. I'm realy for another trial, if they'll have me."
— Phyllis Cronbaugh, 5★

ICON - Lenexa

★ 3.3
9755 Ridge Dr, Lenexa, KS 66219
(913) 410-2000
"Boy they have really gone downhill!!! I went in for a cholesterol study. They wanted people with high cholesterol and not on medication. I even told …"
— Cathie Sims, 1★

Analab Clinical Research, Inc.

★ 5.0
15335 W 95th St, Lenexa, KS 66219
(913) 221-0421

Kansas City Research Institute

★ 5.0
6667 Holmes Rd Ste 129, Kansas City, MO 64131
(816) 759-5274
"Professional, quick & efficient"
— Michael Fleschman, 5★

Dr. Vince Clinical Research

★ 4.5
7401 W 91st St, Overland Park, KS 66212
(913) 333-3000
"Very good experience!!! Staff, roommates, doctors all of them lovely 🥰🥳🫶👍 thank you Kat for an amazing first time in there 😊🤩 see you soon!!!"
— Sara H, 5★

University of Kansas Medical Center Research Institute

★ 5.0
3901 Rainbow Blvd, Kansas City, KS 66160
(913) 588-1261
"The doctors are very nice and helpful."
— Everian Williams, 5★

DelRicht Research of Overland Park Clinical Trials | Dr. Jonathan Jacobs

★ 4.9
5701 W 119th St #242, Overland Park, KS 66209
(913) 391-7188
"Do not go there. Showed up for the appointment after receiving a call to confirm the day before. Lady walked out and told us that the study was fille…"
— Cliff Pitts, 1★

Neuroscience Research Center, LLC

10995 Quivira Rd, Overland Park, KS 66210
(913) 825-2314

The University of Kansas Clinical Research Center

★ 4.8 (6 reviews)
4350 Shawnee Mission Pkwy, Fairway, KS 66205
(913) 588-1227
"Westwood Internal Medicine is staffed with healthcare professionals who are well trained. Their credentials are impressive and well served to the hig…"
— Rebecca Jones, 5★

Clinical trials in Olathe: what's recruiting

The Olathe area currently has 1,042 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Olathe, the most active research areas are:

  • Cancer & Oncology12 studies
  • Lungs & Breathing2 studies
  • Brain & Mental Health2 studies
  • Immune & Skin1 studies

Every listing shows the study phase, the recruiting site and its distance from Olathe, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Olathe

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Olathe participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Olathe pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Olathe?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
How do I join a study in Olathe, KS?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Olathe?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Olathe?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Olathe.

Paid clinical trials near Olathe

Other metros within reach

Overland Park, KS1,034 Kansas City, KS1,046 Kansas City, MO1,035 Topeka, KS113 Springfield, MO153 Columbia, MO248 Lincoln, NE160 Omaha, NE600

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Olathe Bladder Issues Due To Spinal Cord Injury in Olathe All conditions

More of KS

Kansas City1,046 Overland Park1,034 Wichita162 Topeka113

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts